Antiviral Activities of Mastoparan-L-Derived Peptides against Human Alphaherpesvirus 1
Viruses · 2024
DOI: 10.3390/v16060948 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Liana Costa Pereira Vilas Boas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pós-Graduação em Patologia Molecular, Campus Darcy Ribeiro, Universidade de Brasília, Brasília 70910-900, DF, Brazil. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Antiviral Agents, Peptides, Wasp Venoms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul.
Abstract (Originalsprache)
Human alphaherpesvirus 1 (HSV-1) is a significantly widespread viral pathogen causing recurrent infections that are currently incurable despite available treatment protocols. Studies have highlighted the potential of antimicrobial peptides sourced from Vespula lewisii venom, particularly those belonging to the mastoparan family, as effective against HSV-1. This study aimed to demonstrate the antiviral properties of mastoparans, including mastoparan-L [I5, R8], mastoparan-MO, and [I5, R8] mastoparan, against HSV-1. Initially, Vero cell viability was assessed in the presence of these peptides, followed by the determination of antiviral activity, mechanism of action, and dose-response curves through plaque assays. Structural analyses via circular dichroism and nuclear magnetic resonance were conducted, along with evaluating membrane fluidity changes induced by [I5, R8] mastoparan using fluorescence-labeled lipid vesicles. Cytotoxic assays revealed high cell viability (>80%) at concentrations of 200 µg/mL for mastoparan-L and mastoparan-MO and 50 µg/mL for [I5, R8] mastoparan. Mastoparan-MO and [I5, R8] mastoparan exhibited over 80% HSV-1 inhibition, with up to 99% viral replication inhibition, particularly in the early infection stages. Structural analysis indicated an α-helical structure for [I5, R8] mastoparan, suggesting effective viral particle disruption before cell attachment. Mastoparans present promising prospects for HSV-1 infection control, although further investigation into their mechanisms is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pós-Graduação em Patologia Molecular, Campus Darcy Ribeiro, Universidade de Brasília, Brasília 70910-900, DF, Brazil.
- Centro de Análises Bioquímicas e Proteômicas, Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília 70790-760, DF, Brazil.
- Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande 79117-900, MS, Brazil.
- Laboratório de Ressonância Magnética Nuclear, Instituto de Química, Universidade Federal de Goiás, Goiânia 74690-900, GO, Brazil.
- Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal.
ORCID-Profile: Bruno de Paula Oliveira Santos, Luciano Morais Lião, Sónia Gonçalves, Nuno C Santos, Octávio Luiz Franco
Förderung
- National Council for Scientific and Technological Development
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul
- Foundation for Research Support of the Federal District
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Fundação de Amparo à Pesquisa do Distrito Federal (FAPDF)
- Fundação para a Ciência e a Tecnologia—Ministério da Ciência, Tecnologia e Ensino Superior (FCT-MCTES, Portugal)
Zitieren
APA
Vilas Boas, L. C. P., Buccini, D. F., Berlanda, R. L. A., Santos, B. P. O., Maximiano, M. R., Lião, L. M., Gonçalves, S., Santos, N. C., & Franco, O. L. (2024). Antiviral Activities of Mastoparan-L-Derived Peptides against Human Alphaherpesvirus 1. Viruses. https://doi.org/10.3390/v16060948
Vancouver
Vilas Boas LCP, Buccini DF, Berlanda RLA, Santos BPO, Maximiano MR, Lião LM, et al. Antiviral Activities of Mastoparan-L-Derived Peptides against Human Alphaherpesvirus 1. Viruses. 2024. doi:10.3390/v16060948
BibTeX
@article{VilasBoas2024,
author = {Vilas Boas, Liana Costa Pereira and Buccini, Danieli Fernanda and Berlanda, Rhayfa Lorrayne Araújo and Santos, Bruno de Paula Oliveira and Maximiano, Mariana Rocha and Lião, Luciano Morais and Gonçalves, Sónia and Santos, Nuno C and Franco, Octávio Luiz},
title = {Antiviral Activities of Mastoparan-L-Derived Peptides against Human Alphaherpesvirus 1},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16060948}
}
EUVIMED